178 related articles for article (PubMed ID: 857138)
1. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
Mertz DP
Med Klin; 1977 Apr; 72(15):664-8. PubMed ID: 857138
[TBL] [Abstract][Full Text] [Related]
2. [The effect of benzbromaron in gout patients with limited kidney function].
Kuzmits R; Bresnik W; Müller MM
Fortschr Med; 1979 Nov; 97(44):2057-61. PubMed ID: 511087
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)].
Matzkies F; Berg G
Dtsch Med Wochenschr; 1976 Oct; 101(43):1568-70. PubMed ID: 991731
[TBL] [Abstract][Full Text] [Related]
4. Benzbromarone therapy in management of refractory gout.
Kumar S; Ng J; Gow P
N Z Med J; 2005 Jun; 118(1217):U1528. PubMed ID: 15980902
[TBL] [Abstract][Full Text] [Related]
5. [The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies (author's transl)].
Mertz DP
MMW Munch Med Wochenschr; 1978 Oct; 120(42):1387-90. PubMed ID: 101792
[TBL] [Abstract][Full Text] [Related]
6. [Reducing the risks in the treatment of gout and hyperuricaemia (author's transl)].
Mertz DP
Dtsch Med Wochenschr; 1976 Aug; 101(35):1288-92. PubMed ID: 782809
[No Abstract] [Full Text] [Related]
7. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
Matzkies F; Neuwirth R; Berg G
Fortschr Med; 1976 Sep; 94(26):1427-9. PubMed ID: 976920
[TBL] [Abstract][Full Text] [Related]
8. Does benzbromarone in therapeutic doses raise renal excretion of oxipurinol?
Mertz DP; Eichhorn R
Klin Wochenschr; 1984 Dec; 62(24):1170-2. PubMed ID: 6530890
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of urinary calculi by means of a benzbromarone-citrate combination].
Bach D; Hesse A; Strenge A; Vahlensieck W
Fortschr Med; 1980 Nov; 98(44):1752-5. PubMed ID: 7461567
[TBL] [Abstract][Full Text] [Related]
10. [Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study].
Arntz HR; Dreykluft HR; Leonhardt H
Fortschr Med; 1979 Jul; 97(27):1212-4. PubMed ID: 457017
[TBL] [Abstract][Full Text] [Related]
11. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
[TBL] [Abstract][Full Text] [Related]
12. [Excretion and serum concentrations of allopurinol, oxipurinol and oxipurines in combined treatment with allopurinol and benzbromarone in increasing doses].
Mertz DP; Borner K
Med Welt; 1983 Sep; 34(36):974-9. PubMed ID: 6633222
[No Abstract] [Full Text] [Related]
13. [Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver].
Mertz DP
Fortschr Med; 1983 May; 101(18):851-3. PubMed ID: 6862346
[No Abstract] [Full Text] [Related]
14. [Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout].
Zöllner N; Griebsch A; Fink JK
Dtsch Med Wochenschr; 1970 Nov; 95(48):2405-12. PubMed ID: 5480261
[No Abstract] [Full Text] [Related]
15. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output.
Perez-Ruiz F; Calabozo M; Erauskin GG; Ruibal A; Herrero-Beites AM
Arthritis Rheum; 2002 Dec; 47(6):610-3. PubMed ID: 12522834
[TBL] [Abstract][Full Text] [Related]
16. [Uric acid lowering effects of benzbromarone (Harolan) by increasing uric acid excretion].
Fortschr Med; 1979 May; 97(17):835-6. PubMed ID: 437646
[No Abstract] [Full Text] [Related]
17. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
Hanvivadhanakul P; Akkasilpa S; Deesomchok U
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443
[TBL] [Abstract][Full Text] [Related]
18. Influence of urate-lowering therapies on renal handling of uric acid.
Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L
Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449
[TBL] [Abstract][Full Text] [Related]
19. [Long lasting normalization of uric acid after combination therapy with 300 mg allopurinol and 60 mg benzbromarone in patients with gout and hyperuricemia].
Matzkies F
Med Klin (Munich); 1992 Sep; 87(9):460-2. PubMed ID: 1406482
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
